C-MER Eye Care Holdings Limited (3309) Stock Statistics & Valuation Metrics

C-MER Eye Care Holdings Limited has a market cap or net worth of HK$2.11B. The enterprise value is ―.

C-MER Eye Care Holdings Limited has 1,255,560,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

C-MER Eye Care Holdings Limited’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -3.84%.

The current PE Ratio of C-MER Eye Care Holdings Limited is -18.34. C-MER Eye Care Holdings Limited’s PEG ratio is 0.05.

In the last 12 months, C-MER Eye Care Holdings Limited had revenue of 1.91B and earned -135.16M in profits. Earnings per share was -0.11.

In the last 12 months, operating cash flow was 135.43M and capital expenditures -84.04M, giving a free cash flow of 51.39M billion.

C-MER Eye Care Holdings Limited pays an annual dividend of HK$0.019, resulting in a dividend yield of ―

C-MER Eye Care Holdings Limited upcoming earnings date is Sep 2, 2025, TBA Not Confirmed.

C-MER Eye Care Holdings Limited as a current ratio of 1.56, with Debt / Equity ratio of 24.98%

In the past 12 months, C-MER Eye Care Holdings Limited has paid 32.09M in taxes.

C-MER Eye Care Holdings Limited EV to EBITDA ratio is 11.92, with an EV/FCF ratio of 20.18.

C-MER Eye Care Holdings Limited has HK$467.25M in cash and marketable securities with HK$437.79M in debt, giving a net cash position of -HK$29.46M billion.

Gross margin is 31.20%, with operating margin of -3.46%, and net profit margin of -7.06%.

The average price target for C-MER Eye Care Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―